Freedom from Structural Valve Deterioration

Author Year No. of
Patients
Type of
Study
Type of
Valve
Mean Age at Implant Mean
Follow-Up (yrs)
5 years
(%)
10 years
(%)
15 years
(%)
20 years
(%)
25 years
(%)
Linearized rate
(% per pt year)
Cohn et al, 1998 843 Prospective Follow-Up Hancock modified orifice porcine 69 6 99 79 57 - - -
Khan et al, 1998 243 Retrospective Hancock Porcine 68 7 - - - - - -
Poirier et al, 1998 598 Prospective Follow-Up *CE bovine pericardial 65 4.8 99 93 80 (14yr) - - 0.7
Banbury et al, 2001 267 Prospective Follow-Up CE bovine pericardial 65 12 99 94 77 - - -
David et al, 2001 670 Prospective Follow-Up Hancock II porcine 65 7.3 100 97 81 - - -
Jamieson et al, 2006 1823 Prospective Follow-Up CE supra-annular porcine 69 7.9 - 89 (12yr) 75 - -  
Jamieson et al, 2006 1430 Prospective Follow-Up CE perimount pericardial 70 5.4 - 93 (12yr) 88 - -  
Rizzoli et al, 2006 809 Prospective Follow-Up Hancock II porcine 68 12 100 97 85 - - -
Jamieson et al, 2009 381 Retrospective Mitroflow pericardial 76 5.4 99 86 - - - 0.8
Myken et al, 2009 1518 Prospective Follow-Up St. Jude Medical Biocor 71 6 - - - 61* - 0.9
David et al, 2010 1134 Prospective Follow-Up Hancock II porcine 67 12.2 99 98 87 63 - -
McClure et al, 2010 1000 Prospective Follow-Up CE bovine pericardial 74 6 99 97 82 - - -
Riess et al, 2010 255 Prospective Follow-Up Medtronic Mosaic porcine 69 8.3 100 (4yr) 100 (8yr) 85 (13yr) - - 0.5
ISTHMUS 2011 1591 Retrospective Mitroflow pericardial 75 5.2 - - - 66 (18yr) - 1.4
Jamieson et al, 2011 797 Prospective Follow-Up Medtronic Mosaic porcine 69 7.5 100** 95** 91 (12yr)** - - -
Aaron J. Weiss M.D., Stephen M. Spindel M.D., and Farzan Filsoufi M.D.
* CE = Carpentier-Edwards
** Values correspond to actuarial freedom from reoperation because of structural valve deterioration (SVD). Patients that had SVD without reoperation were not detailed in this study.

  1. Cohn LH, Collins JJ, Jr., Rizzo RJ, et al. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998;66:S30-4.
  2. Khan SS, Chaux A, Blanche C, et al. A 20-year experience with the Hancock porcine xenograft in the elderly. Ann Thorac Surg 1998;66:S35-9.
  3. Poirer NC, Pelletier LC, Pellerin M, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66:S57-61.
  4. Banbury MK, Cosgrove DM, 3rd, White JA, et al. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-7.
  5. David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-77.
  6. Jamieson WR, Germann E, Aupart MR, et al. 15-year comparison of supra-annular porcine and PERIMOUNT aortic bioprostheses. Asian Cardiovasc Thorac Ann 2006;14:200-5.
  7. Rizzoli G, Mirone S, Ius P, et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg 2006;132:602-9, 609 e1-4.
  8. Jamieson WR, Koerfer R, Yankah CA, et al. Mitroflow aortic pericardial bioprosthesis--clinical performance. Eur J Cardiothorac Surg 2009;36:818-24.
  9. Myken PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 2009;137:76-81.
  10. David TE, Armstrong S, Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg 2010;90:775-81.
  11. McClure RS, Narayanasamy N, Wiegerinck E, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010;89:1410-6.
  12. Riess FC, Cramer E, Hansen L, et al. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg 2010;37:145-53.
  13. Investigators I. The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis. Eur J Cardiothorac Surg 2011;39:18-26; discussion 26.
  14. Jamieson WR, Riess FC, Raudkivi PJ, et al. Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg 2011;142:302-7 e2.